A high-dose cytarabine regimen was used as consolidation chemotherapy for patients with acute myeloid leukaemia. It has been replaced with age specific dose regimens, however, the general principle is the same.
The new consolidation cytarabine regimens (age over or under 60) are two to four cycles of 28 days. Cytarabine is given bis in die on days one, two, and three.